HPSE, heparanase, 10855

N. diseases: 393; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 Biomarker disease BEFREE Applying patient-derived lung cancer xenografts and a potent inhibitor of heparanase enzymatic activity (PG545) we investigated the significance of heparanase in the pathogenesis of lung cancer. 29721203 2018
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 Biomarker disease BEFREE CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer. 23649655 2013
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 AlteredExpression disease BEFREE This study aims to discuss the correlation between miR-1258 and the expression of heparanase (HPSE) in the cancer cells of the patients with non-small cell lung cancer (NSCLC) and the inhibition mechanism of miR-1258 on the invasion of lung cancer cell. 22488243 2012
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 Biomarker disease BEFREE In this study, we evaluated the inhibitory effect of HPSE antisense oligoxydeonucleotide (ASODN) on lung carcinoma cell line A-549 invasion. 22471483 2011
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.050 AlteredExpression disease BEFREE We investigated the effect of three growth factors, platelet-derived growth factor (PDGF), hepatocyte growth factor (HGF) and basic fibroblast growth factor (bFGF), on heparanase mRNA induction in lung cancer cells in vitro. 11759110 2001